William Blair Upgrades DENTSPLY SIRONA (NASDAQ:XRAY) to “Outperform”

DENTSPLY SIRONA (NASDAQ:XRAY) was upgraded by investment analysts at William Blair from a “market perform” rating to an “outperform” rating in a research report issued on Friday, MarketBeat.com reports.

Several other research firms have also recently commented on XRAY. Evercore ISI cut their target price on shares of DENTSPLY SIRONA from $45.00 to $36.00 in a research note on Wednesday, October 11th. Stifel Nicolaus cut their target price on shares of DENTSPLY SIRONA from $41.00 to $35.00 and set a “hold” rating for the company in a research note on Wednesday, November 1st. StockNews.com upgraded shares of DENTSPLY SIRONA from a “hold” rating to a “buy” rating in a research note on Tuesday, November 7th. Piper Sandler cut their target price on shares of DENTSPLY SIRONA from $42.00 to $39.00 and set a “neutral” rating for the company in a research note on Friday, September 22nd. Finally, The Goldman Sachs Group lowered their price target on shares of DENTSPLY SIRONA from $42.00 to $36.00 and set a “neutral” rating on the stock in a report on Tuesday, November 7th. Three analysts have rated the stock with a hold rating and four have issued a buy rating to the company’s stock. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus price target of $39.75.

DENTSPLY SIRONA Price Performance

Shares of DENTSPLY SIRONA stock opened at $28.39 on Friday. The firm has a fifty day simple moving average of $32.75 and a 200-day simple moving average of $37.05. The company has a current ratio of 1.57, a quick ratio of 1.04 and a debt-to-equity ratio of 0.53. DENTSPLY SIRONA has a 1-year low of $26.27 and a 1-year high of $43.24. The stock has a market capitalization of $6.01 billion, a price-to-earnings ratio of -28.11, a PEG ratio of 1.88 and a beta of 0.99.

DENTSPLY SIRONA (NASDAQ:XRAY) last released its earnings results on Thursday, November 2nd. The medical instruments supplier reported $0.49 EPS for the quarter, beating the consensus estimate of $0.48 by $0.01. The firm had revenue of $947.00 million during the quarter, compared to analysts’ expectations of $975.21 million. DENTSPLY SIRONA had a negative net margin of 5.44% and a positive return on equity of 10.91%. The business’s quarterly revenue was up .0% compared to the same quarter last year. During the same period in the prior year, the company earned $0.41 EPS. On average, sell-side analysts expect that DENTSPLY SIRONA will post 1.82 earnings per share for the current year.

Institutional Investors Weigh In On DENTSPLY SIRONA

Several large investors have recently made changes to their positions in the company. Deutsche Bank AG grew its holdings in shares of DENTSPLY SIRONA by 12.0% in the 3rd quarter. Deutsche Bank AG now owns 771,684 shares of the medical instruments supplier’s stock worth $26,361,000 after purchasing an additional 82,840 shares during the last quarter. Andra AP fonden grew its holdings in shares of DENTSPLY SIRONA by 20.3% in the 3rd quarter. Andra AP fonden now owns 302,700 shares of the medical instruments supplier’s stock worth $10,340,000 after purchasing an additional 51,100 shares during the last quarter. Oliver Luxxe Assets LLC grew its holdings in shares of DENTSPLY SIRONA by 225.9% in the 3rd quarter. Oliver Luxxe Assets LLC now owns 59,329 shares of the medical instruments supplier’s stock worth $2,027,000 after purchasing an additional 41,126 shares during the last quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS grew its holdings in shares of DENTSPLY SIRONA by 14.9% in the 3rd quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS now owns 42,569 shares of the medical instruments supplier’s stock worth $1,454,000 after purchasing an additional 5,512 shares during the last quarter. Finally, Sasco Capital Inc. CT grew its holdings in shares of DENTSPLY SIRONA by 32.4% in the 3rd quarter. Sasco Capital Inc. CT now owns 839,250 shares of the medical instruments supplier’s stock worth $28,669,000 after purchasing an additional 205,440 shares during the last quarter. Institutional investors own 95.70% of the company’s stock.

About DENTSPLY SIRONA

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies for professional dental market worldwide. The company operates through two segments, Technologies & Equipment, and Consumables. The Technologies & Equipment segment provides dental equipment, such as treatment centers, imaging equipment, motorized dental handpieces, and other instruments for dental practitioners and specialists; dental CAD/CAM technologies for dental offices to support various digital dental procedures, including dental restorations; dentist-directed aligner solutions, SureSmile, and direct-to-consumer clear aligner solutions, as well as high frequency vibration technology device; implants; and urology catheters and other healthcare-related consumable products.